Terry J. Rosen Purchases 66,666 Shares of Arcus Biosciences Inc (NYSE:RCUS) Stock

Arcus Biosciences Inc (NYSE:RCUS) CEO Terry J. Rosen bought 66,666 shares of the company’s stock in a transaction that occurred on Monday, March 19th. The stock was bought at an average cost of $15.00 per share, for a total transaction of $999,990.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

NYSE RCUS opened at $13.55 on Wednesday. Arcus Biosciences Inc has a 12 month low of $13.27 and a 12 month high of $22.10.

A number of research analysts recently commented on RCUS shares. Citigroup started coverage on shares of Arcus Biosciences in a research report on Monday. They issued a “buy” rating and a $18.00 target price on the stock. Leerink Swann started coverage on shares of Arcus Biosciences in a research report on Monday. They issued an “outperform” rating and a $21.00 target price on the stock. Finally, Goldman Sachs started coverage on shares of Arcus Biosciences in a research report on Monday. They issued a “neutral” rating and a $18.00 target price on the stock.

TRADEMARK VIOLATION NOTICE: This story was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.thelincolnianonline.com/2018/04/11/arcus-biosciences-inc-rcus-ceo-terry-j-rosen-purchases-66666-shares.html.

Receive News & Ratings for Arcus Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcus Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply